Cosibelimab
TG-1501-101
Phase 1 small_molecule terminated
Quick answer
Cosibelimab for B-cell Non Hodgkin Lymphoma is a Phase 1 program (small_molecule) at TG THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- B-cell Non Hodgkin Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated